GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes.
Vincenzo TrischittaAlessandra AntonucciJerzy AdamskiCornelia PrehnClaudia MenzaghiAntonella MarucciRosa Di PaolaPublished in: Acta diabetologica (2024)
Our data indicate that in type 2 diabetes the expression of GALNT2 is associated with several serum metabolites. This association needs to be further investigated to understand in depth its role in mediating the effect of GALNT2 on insulin sensitivity, glucose control and other clinical features in people with diabetes.